Boustani, M, Campbell, N, Munger, S, Maidment, I, Fox, C. Impact of anticholinergics on the aging brain: a
review and practical application. Aging
2008; 4: 311–20.
Smithard, DG, Fox, C, Maidment, ID, Katona, C, Boustani, M. Do anticholinergic drugs contribute to functional
and cognitive decline?
Campbell, N, Boustani, M, Limbil, T, Ott, C, Fox, C, Maidment, I, et al. The cognitive impact of anticholinergics: a
clinical review. Clin Interv Aging
2009; 4: 225.
Flacker, JM, Cummings, V, Mach, JR Jr, Bettin, K, Kiely, DK, Wei, J. The association of serum anticholinergic activity
with delirium in elderly medical patients. Am J
O'Mahony, D, O'Sullivan, D, Byrne, S, O'Connor, MN, Ryan, C, Gallagher, P. STOPP/START criteria for potentially inappropriate
prescribing in older people: version 2. Age
2015; 44: 213–8.
Ruxton, K, Woodman, RJ, Mangoni, AA. Drugs with anticholinergic effects and cognitive
impairment, falls and all-cause mortality in older adults: a systematic
review and meta-analysis. Br J Clin
2015; 80: 209–20.
Gray, SL, Anderson, ML, Dublin, S, Hanlon, JT, Hubbard, R, Walker, R, et al. Cumulative use of strong anticholinergics and
incident dementia: a prospective cohort study.
2015; 175: 401–7.
Heslop, P, Blair, PS, Fleming, P, Hoghton, M, Marriott, A, Russ, L. The Confidential Inquiry into premature deaths of
people with intellectual disabilities in the UK: a population-based
2014; 383: 889–95.
Buszewicz, M, Welch, C, Horsfall, L, Nazareth, I, Osborn, D, Hassiotis, A, et al. Assessment of an incentivised scheme to
provide annual health checks in primary care for adults with intellectual
disability: a longitudinal cohort study. Lancet
2014; 1: 522–30.
Haveman, M, Heller, T, Lee, L, Maaskant, M, Shooshtari, S, Strydom, A. Major health risks in aging persons with
intellectual disabilities: an overview of recent studies.
J Policy Pract Intellect Disabil
Haveman, M, Perry, J, Salvador-Carulla, L, Walsh, PN, Kerr, M, Van Schrojenstein, LV, et al. Ageing and health status in adults with
intellectual disabilities: results of the European POMONA II
study. J Intellect Dev Disabil
McCarron, M, O'Dwyer, M, Burke, E, McGlinchey, E, McCallion, P. Epidemiology of epilepsy in older adults with an
intellectual disability in Ireland: associations and service
implications. Am J Intellect Dev Disabil
2014; 119: 253–60.
Cooper, S-A, Smiley, E, Morrison, J, Williamson, A, Allan, L. Mental ill-health in adults with intellectual
disabilities: prevalence and associated factors.
Br J Psychiatry
Tyrer, P, Cooper, S-A, Hassiotis, A. Drug treatments in people with intellectual
disability and challenging behaviour.
National Audit Office. Care Services for People
with Learning Disabilities and Challenging Behaviour: Report by the
Comptroller and Auditor General. National Audit
Department of Health. Transforming Care: A National
Response to Winterbourne View Hospital.
Department of Health Review Final Report. Department of
Bhaumik, S, Branford, D. The Frith Prescribing Guidelines for Adults with Learning
Disability: United Kingdom. Taylor and
Han, L, Agostini, JV, Allore, HG. Cumulative anticholinergic exposure is associated
with poor memory and executive function in older men.
J Am Geriatr Soc
2008; 56: 2203–10.
Mintzer, J, Burns, A. Anticholinergic side-effects of drugs in elderly
people. J Roy Soc Med
2000; 93: 457.
Fox, C, Richardson, K, Maidment, ID, Savva, GM, Matthews, FE, Smithard, D, et al. Anticholinergic medication use and cognitive
impairment in the older population: the Medical Research Council
Cognitive Function and Ageing study. J Am Geriatr
2011; 59: 1477–83.
Salahudeen, MS, Hilmer, SN, Nishtala, PS. Comparison of anticholinergic risk scales and
associations with adverse health outcomes in older
people. J Am Geriatr Soc
McCarron, M, Swinburne, J, Burke, E, McGlinchey, E, Mulryan, N, Andrews, V, et al. Growing Older with an Intellectual Disability in
Ireland 2011: First Results from the Intellectual Disability Supplement
of The Irish Longitudinal Study on Ageing School of Nursing.
School of Midwifery and Nursing, Trinity College
McCarron, M, Swinburne, J, Burke, E, McGlinchey, E, Carroll, R, McCallion, P. Patterns of multimorbidity in an older population of
persons with an intellectual disability: results from the intellectual
disability supplement to the Irish longitudinal study on aging
(IDS-TILDA). Res Dev Disabil
2013; 34: 521–7.
Janicki, MP, Dalton, AJ. Dementia and Aging Adults with Intellectual Disabilities: A
Lavin, KE, McGuire, BE, Hogan, MJ. Age at death of people with an intellectual
disability in Ireland. J Intellect
2006; 10: 155–64.
Vandenbroucke, JP, von Elm, E, Altman, DG, Gøtzsche, PC, Mulrow, CD, Pocock, SJ, et al. Strengthening the reporting of observational
studies in epidemiology (STROBE): Explanation and
elaboration. Int J Surg
2014; 12: 1500–24.
World Health Organization. Anatomical Chemical
Therapeutic Classification System.
Mac Giolla Phadraig, C, McCallion, P, Cleary, E, McGlinchey, E, Burke, E, McCarron, M, et al. Total tooth loss and complete denture use in
older adults with intellectual disabilities in Ireland.
J Public Health Dent
2014; 75: 101–8.
Tabachnick, B, Fidell, LS. Using Multivariate Statistics (6th
Peduzzi, P, Concato, J, Kemper, E, Holford, TR, Feinstein, AR. A simulation study of the number of events per
variable in logistic regression analysis. J Clin
1996; 49: 1373–9.
Benjamini, Y, Hochberg, Y. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J
Royal Stat Soc Series B Stat Methodol
Myint, PK, Fox, C, Kwok, CS, Luben, RN, Wareham, NJ, Khaw, K-T. Total anticholinergic burden and risk of mortality
and cardiovascular disease over 10 years in 21,636 middle-aged and older
men and women of EPIC-Norfolk prospective population
study. Age Ageing
2014: 44: 219–25.
Richardson, K, Bennett, K, Maidment, ID, Fox, C, Smithard, D, Kenny, RA. Use of medications with anticholinergic activity and
self-reported injurious falls in older community-dwelling
adults. J Am Geriatr Soc
2015; 63: 1561–9.
Tsiouris, JA, Kim, S-Y, Brown, WT, Pettinger, J, Cohen, IL. Prevalence of psychotropic drug use in adults with
intellectual disability: positive and negative findings from a large
scale study. J Autism Dev Disord
2013: 43: 732.
Stolker, JJ, Heerdink, ER, Leufkens, HG, Clerkx, MG, Nolen, WA. Determinants of multiple psychotropic drug use in
patients with mild intellectual disabilities or borderline intellectual
functioning and psychiatric or behavioral disorders.
Gen Hosp Psychiatry
2001; 23: 345–9.
Haider, SI, Ansari, Z, Vaughan, L, Matters, H, Emerson, E. Prevalence and factors associated with polypharmacy
in Victorian adults with intellectual disability.
Res Dev Disabil
2014; 35: 3071–80.
Qato, DM, Alexander, GC, Conti, RM, Johnson, M, Schumm, P, Lindau, ST. Use of prescription and over-the-counter medications
and dietary supplements among older adults in the United
2008; 300: 2867–78.
Paton, C, Flynn, A, Shingleton-Smith, A, McIntyre, S, Bhaumik, S, Rasmussen, J, et al. Nature and quality of antipsychotic
prescribing practice in UK psychiatry of intellectual disability
services. J Intellect Disabil Res
2011; 55: 665–74.
Banerjee, S. The Use of Antipsychotic Medication for People with
Dementia: Time for Action. Department of
Taylor, D, Paton, C, Kapur, S. The Maudsley Prescribing Guidelines in Psychiatry.
John Wiley & Sons,
Lu, W-H, Wen, Y-W, Chen, L-K, Hsiao, F-Y. Effect of polypharmacy, potentially inappropriate
medications and anticholinergic burden on clinical outcomes: a
retrospective cohort study. CAMJ
Gallagher, P, O'Mahony, D. Constipation in old age.
Best Pract Res Clin Gastroenterol
2009; 23: 875–87.
Böhmer, C, Taminiau, J, Klinkenberg-Knol, E, Meuwissen, S. The prevalence of constipation in institutionalized
people with intellectual disability. J Intellect
2001; 45: 212–8.
Gil-Montoya, JA, de Mello, ALF, Barrios, R, Gonzalez-Moles, MA, Bravo, M. Oral health in the elderly patient and its impact on
general well-being: a nonsystematic review. Clin
2015; 10: 46.
Gøtzsche, PC, Young, AH, Crace, J. Does long term use of psychiatric drugs cause more
harm than good?
Gerretsen, P, Pollock, BG. Drugs with anticholinergic properties: a current
perspective on use and safety. Exp Opin Drug
2011; 10: 751–65.
Oliver, D. Guest editorial: Integrated services for older
people – the key to unlock our health and care services and improve the
quality of care?
J Res Nurs
Maidment, ID, Haw, C, Stubbs, J, Fox, C, Katona, C, Franklin, BD. Medication errors in older people with mental health
problems: a review. Int J Geriatr
2008; 23: 564–73.
McCartney, M. Drugs with anticholinergic side effects and
cognitive decline – cause or effect?
Freedman, RI. Ethical challenges in the conduct of research
involving persons with mental retardation. Mental
2001; 39: 130–41.
Chew, ML, Mulsant, BH, Pollock, BG, Lehman, ME, Greenspan, A, Mahmoud, RA, et al. Anticholinergic activity of 107 medications
commonly used by older adults. J Am Geriatr
2008; 56: 1333–41.